| Dr Travis James, DO | |
|
169 N Gateway Dr Ste 100, Providence, UT 84332-9860 | |
| (435) 554-1182 | |
| (435) 554-1950 |
| Full Name | Dr Travis James |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 169 N Gateway Dr Ste 100, Providence, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477818920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OP 60613648 (Washington) | Secondary |
| 207N00000X | Dermatology | O-0902 (Idaho) | Secondary |
| 207N00000X | Dermatology | 11293840-1204 (Utah) | Primary |
| Entity Name | Cbm Derm Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568029957 PECOS PAC ID: 9032541693 Enrollment ID: O20191120000665 |
News Archive
Nonprescription medications are just as likely a cause of poisoning as prescription drugs, according to a new study by Timothy Wiegand, M.D. from the University of Rochester Medical Center in the US and colleagues.
We looked at all hospitalizations in patients with gout. The concern is that gout is often considered as a disease of just the joints, specifically of the big toe. Yet, there have been quite a lot of studies that have talked about the many other comorbidities that occur because of hyperuricemia and gout. The idea is that it's not just the crystal deposits in the joint, but other consequences that are happening because of this disease in the rest of the body.
Polyganics today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL, its dura sealant patch.
New York University College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Travis James, DO 169 N Gateway Dr Ste 100, Providence, UT 84332-9860 Ph: (435) 752-5741 | Dr Travis James, DO 169 N Gateway Dr Ste 100, Providence, UT 84332-9860 Ph: (435) 554-1182 |
News Archive
Nonprescription medications are just as likely a cause of poisoning as prescription drugs, according to a new study by Timothy Wiegand, M.D. from the University of Rochester Medical Center in the US and colleagues.
We looked at all hospitalizations in patients with gout. The concern is that gout is often considered as a disease of just the joints, specifically of the big toe. Yet, there have been quite a lot of studies that have talked about the many other comorbidities that occur because of hyperuricemia and gout. The idea is that it's not just the crystal deposits in the joint, but other consequences that are happening because of this disease in the rest of the body.
Polyganics today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL, its dura sealant patch.
New York University College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen.
› Verified 6 days ago